Correlation Between Immix Biopharma and Allovir
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Allovir, you can compare the effects of market volatilities on Immix Biopharma and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Allovir.
Diversification Opportunities for Immix Biopharma and Allovir
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Immix and Allovir is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Allovir go up and down completely randomly.
Pair Corralation between Immix Biopharma and Allovir
Given the investment horizon of 90 days Immix Biopharma is expected to generate 0.93 times more return on investment than Allovir. However, Immix Biopharma is 1.07 times less risky than Allovir. It trades about 0.09 of its potential returns per unit of risk. Allovir is currently generating about -0.04 per unit of risk. If you would invest 181.00 in Immix Biopharma on September 12, 2024 and sell it today you would earn a total of 51.00 from holding Immix Biopharma or generate 28.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Allovir
Performance |
| Timeline |
| Immix Biopharma |
| Allovir |
Immix Biopharma and Allovir Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Allovir
The main advantage of trading using opposite Immix Biopharma and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Allovir vs. Anebulo Pharmaceuticals | Allovir vs. Mineralys Therapeutics, Common | Allovir vs. AN2 Therapeutics | Allovir vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |